Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Omega-3 fatty acids have been investigated for their potential benefits in supporting cancer patients, particularly in reducing the side effects of cancer treatment. Scientific evidence suggests that omega-3 supplementation may help mitigate some negative effects of chemotherapy and other cancer therapies, such as inflammation, weight loss (cachexia), and immune dysfunction. Several clinical studies have shown that omega-3 fatty acids, especially EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), can help maintain or improve nutritional status, reduce the risk of muscle wasting, and modulate inflammatory responses in cancer patients undergoing treatment.

For example, randomized controlled trials have reported that omega-3 supplementation can attenuate weight loss and improve appetite and quality of life in patients with advanced cancer. Some evidence also points to omega-3s reducing the severity of certain chemotherapy-induced side effects, such as peripheral neuropathy and inflammation. Additionally, omega-3 fatty acids may support immune function, which is often compromised during cancer treatment.

However, while the evidence is promising, it is not universally conclusive. Guidelines from medical organizations often state that more high-quality, large-scale trials are needed to firmly establish the benefits and determine optimal dosing and timing. Therefore, omega-3 fatty acids are sometimes recommended as an adjunctive support in cancer care, but not as a primary or standalone treatment for cancer or its side effects.

More about omega-3 fatty acids
More about Cancer Treatment (reducing side effects)

Other ingredients used for Cancer Treatment (reducing side effects)

Other health conditions supported by omega-3 fatty acids

Products containing omega-3 fatty acids

Nature's Sunshine Flax Seed Oil (With Lignans)